HOWL vs TROW · $48.9M cap vs P/E 12, rev $3.76B
Werewolf Therapeutics Inc (HOWL) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Werewolf Therapeutics Inc (HOWL) is a biotechnology company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
HOWL does not have a complete income-statement cache yet.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
HOWL currently screens at market cap $48.9M. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the HOWL and TROW stock pages for the full models.
Not investment advice.